Old Web
English
Sign In
Acemap
>
authorDetail
>
Michele Libonati
Michele Libonati
Immunology
Natalizumab
Medicine
Pharmacokinetics
Pharmacology
4
Papers
161
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Natalizumab therapy for moderate to severe Crohn disease in adolescents.
2007
Journal of Pediatric Gastroenterology and Nutrition
Jeffrey S. Hyams
David C. Wilson
Adrian G. Thomas
Robert Heuschkel
Sally G. Mitton
Brent Mitchell
Regina Daniels
Michele Libonati
Susan Zanker
Subra Kugathasan
Show All
Source
Cite
Save
Citations (57)
PHARMACOKINETICS AND PHARMACODYNAMICS OF NATALIZUMAB IN A PHASE 2 STUDY OF ADOLESCENT PATIENTS WITH CROHN??S DISEASE: 147
2005
Journal of Pediatric Gastroenterology and Nutrition
John Grundy
Wei-Jian Pan
Subra Kugathasan
Fides Nagpala
Deborah Hilton
Julie Taylor
Ronald Goldblum
Michele Libonati
Regina Daniels
Jeannie Giacchino
Show All
Source
Cite
Save
Citations (7)
An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis
2004
Multiple Sclerosis Journal
Timothy Vollmer
J. T. Phillips
Andrew D. Goodman
Mark A. Agius
Michele Libonati
J. L. Giacchino
J. S. Grundy
Show All
Source
Cite
Save
Citations (41)
Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease ☆
1997
Experimental Neurology
Krzysztof S. Bankiewicz
Stuart E. Leff
Dea Nagy
Steve Jungles
Joseph Rokovich
Kaye Spratt
Lawrence K. Cohen
Michele Libonati
Richard O. Snyder
Ronald J. Mandel
Show All
Source
Cite
Save
Citations (56)
1